M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice
about
Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adultsControl of sleep and wakefulnessA comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairmentUltrasonic vocalizations induced by sex and amphetamine in M2, M4, M5 muscarinic and D2 dopamine receptor knockout mice.The role of the laterodorsal tegmental nucleus in methamphetamine conditioned place preference and locomotor activity.Somatodendritic targeting of M5 muscarinic receptor in the rat ventral tegmental area: implications for mesolimbic dopamine transmissionAttenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation.Acute cocaine exposure elicits rises in calcium in arousal-related laterodorsal tegmental neuronsSeparating analgesia from reward within the ventral tegmental area.Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia.AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release.M₅ muscarinic receptors mediate striatal dopamine activation by ventral tegmental morphine and pedunculopontine stimulation in mice.Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in ratsMuscarinic acetylcholine receptors in the nucleus accumbens core and shell contribute to cocaine priming-induced reinstatement of drug seeking.The role of acetylcholine in cocaine addiction.Age-related changes in nicotine response of cholinergic and non-cholinergic laterodorsal tegmental neurons: implications for the heightened adolescent susceptibility to nicotine addictionAcetylcholine from the mesopontine tegmental nuclei differentially affects methamphetamine induced locomotor activity and neurotransmitter levels in the mesolimbic pathwayMuscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's DiseaseThe laterodorsal tegmentum contributes to behavioral sensitization to amphetamine.Muscarinic acetylcholine receptor binding affinities of pethidine analogs.Exposure to nicotine and sensitization of nicotine-induced behaviorsCholinergic connectivity: it's implications for psychiatric disorders.Acetylcholine release in the mesocorticolimbic dopamine system during cocaine seeking: conditioned and unconditioned contributions to reward and motivation.Ventral tegmental area α6β2 nicotinic acetylcholine receptors modulate phasic dopamine release in the nucleus accumbens core.The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtypeCerebellar modulation of frontal cortex dopamine efflux in mice: relevance to autism and schizophrenia.Affective analgesia following muscarinic activation of the ventral tegmental area in ratsNicotinic activation of laterodorsal tegmental neurons: implications for addiction to nicotine.Lesions of cholinergic pedunculopontine tegmental nucleus neurons fail to affect cocaine or heroin self-administration or conditioned place preference in rats.Increased amphetamine-induced locomotor activity, sensitization, and accumbal dopamine release in M5 muscarinic receptor knockout mice.M5 receptor activation produces opposing physiological outcomes in dopamine neurons depending on the receptor's locationOff the beaten path: drug addiction and the pontine laterodorsal tegmentum.Extended access oxycodone self-administration and neurotransmitter receptor gene expression in the dorsal striatum of adult C57BL/6 J mice.A threshold model for opposing actions of acetylcholine on reward behavior: Molecular mechanisms and implications for treatment of substance abuse disorders.A role for the lateral dorsal tegmentum in memory and decision neural circuitry.Operant responding for optogenetic excitation of LDTg inputs to the VTA requires D1 and D2 dopamine receptor activation in the NAcc.Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulationMicroinjection of M(5) muscarinic receptor antisense oligonucleotide into VTA inhibits FosB expression in the NAc and the hippocampus of heroin sensitized rats.Cholinergic receptor pathways involved in apoptosis, cell proliferation and neuronal differentiation.
P2860
Q21283784-BDF79656-3EB3-4482-9C10-4FF252D29329Q24634619-A754D28E-72B9-46FA-B719-99A69D0082CBQ30475205-C83A5E0E-0EC4-4733-A125-B65F70343EB9Q30496544-2992E885-7F18-4B0E-B76E-4043FB30CBF0Q33609385-D1B2E407-355D-43B2-AE91-32910724CDEBQ33683909-59B4FD61-01F2-415A-90C6-21F539C29E7AQ33714879-B84662C0-92AD-47E5-AC66-498A2851820BQ33771394-84E6DD91-E236-4320-B0B3-32744719E360Q33791677-C7F3E1E4-AF88-42E2-A6D5-32F1B114ED12Q33835219-D43AF0D2-B1EA-4E54-A0DF-9E131F13D59FQ34038767-05C94A8E-46D0-480C-90E9-FD4094E09565Q34076241-50EC3B5E-63B8-4A6D-A254-9EFCAE2F78D2Q34079321-F18861DB-5578-4D05-B962-6483444877DFQ34116719-02F72F02-0AB9-4BDC-9097-B0E91A245063Q34548833-F3BC5538-DAD9-4DCA-A5F7-087A1BDA9E54Q34700186-8C22CE66-01D2-481E-80BE-132688B72E7DQ35174622-8E491773-9EA7-4E8F-B118-8EE90AEB7C2DQ35726276-797C0E04-0D75-4EFF-9038-348B0012B209Q35789730-0AAA4262-9B10-4206-A4AB-235DE60EFECEQ36088209-5A826026-6455-4A14-B331-3FBB2B35734AQ36238735-15F872D0-37F6-4271-AAE5-4E5FDE676F85Q36274171-497613DD-BA52-4423-A45F-BFCFD45EF5FFQ36812599-BBB32488-EDE2-4A3A-BF1E-4046EC1EF0B8Q36924849-57EC8786-9A61-40BB-8058-2EA61A6ED0B4Q37092934-E645B060-A88A-4247-B2DB-7B9992C93A8AQ37309784-0029308F-083F-4918-AA33-B29CC5F7F7C8Q37372557-33BC12CE-8052-4A93-8881-A8C57BADC0DDQ37376567-BADD4CD9-9C9A-4214-8AA7-0F6CDAAD67BBQ37387682-65377A59-8AEB-471D-AD0E-273F31164DAEQ37499189-FFF270E5-A17E-4327-9F97-F945D2242EA0Q37539911-FDF7AA0D-5757-454E-BE59-527B4F08586BQ37603769-CCCD578E-1A89-4EFF-8593-750642227AF4Q38222774-118B55C4-9D26-4307-8E50-D052C65728D5Q38279982-3483B004-D521-421C-8577-6F4F9F873A72Q38851564-4813B7C8-68D6-4304-A34C-57F436681C97Q39178638-F2FA7DF7-56ED-4C74-9956-D01D05BC4F16Q40139136-7A2B08CD-5F4C-4703-B2EF-90345859A4F8Q40370946-B2CAEBC4-FA7E-4D6B-995B-12D7D6A16436Q40955806-B0813CD5-6E75-4DF3-9800-38D870258082Q42556634-4BAC9013-4042-4FDE-B39E-0C102356E0B3
P2860
M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice
description
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2002
@ast
im Januar 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/01/01)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/01/01)
@nl
наукова стаття, опублікована в січні 2002
@uk
مقالة علمية (نشرت عام 2002)
@ar
name
M5 muscarinic receptors are re ...... timulation of the pons in mice
@ast
M5 muscarinic receptors are re ...... timulation of the pons in mice
@en
M5 muscarinic receptors are re ...... timulation of the pons in mice
@nl
type
label
M5 muscarinic receptors are re ...... timulation of the pons in mice
@ast
M5 muscarinic receptors are re ...... timulation of the pons in mice
@en
M5 muscarinic receptors are re ...... timulation of the pons in mice
@nl
prefLabel
M5 muscarinic receptors are re ...... timulation of the pons in mice
@ast
M5 muscarinic receptors are re ...... timulation of the pons in mice
@en
M5 muscarinic receptors are re ...... timulation of the pons in mice
@nl
P2093
P1476
M5 muscarinic receptors are re ...... timulation of the pons in mice
@en
P2093
Charles D Blaha
Gina L Forster
John S Yeomans
Junichi Takeuchi
P356
10.1523/JNEUROSCI.22-01-J0001.2002
P407
P577
2002-01-01T00:00:00Z